about
Circulating tumour cells in metastatic head and neck cancersVariation of Human Salivary O-GlycomeShort term ex-vivo expansion of circulating head and neck tumour cells.Identification of novel antigens in blood vessels in rectovaginal endometriosis.PD-L1 expressing circulating tumour cells in head and neck cancers.Validation of an immunoassay to measure plasminogen-activator inhibitor-1 concentrations in human saliva.One-step homogeneous C-reactive protein assay for saliva.The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle.NT-ProBNP levels in saliva and its clinical relevance to heart failure.Progesterone regulation of implantation-related genes: new insights into the role of oestrogenOestrogen and progestin responses in human endometrium.Current trends in the etiology and diagnosis of HPV-related head and neck cancers.A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patientsSalivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers.Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients.The impact of saliva collection and processing methods on CRP, IgE, and Myoglobin immunoassays.Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human.Enrichment of circulating head and neck tumour cells using spiral microfluidic technology.Impact of label-free technologies in head and neck cancer circulating tumour cells.A Pilot Study into the Association between Oral Health Status and Human Papillomavirus-16 Infection.Diagnostic potential of saliva: current state and future applications.Saliva proteome research: current status and future outlook.miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas.High-yield RNA-extraction method for saliva.A liquid biopsy for head and neck cancers.The current status of heart failure diagnostic biomarkers.Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.Within-Day Baseline Variation in Salivary Biomarkers in Healthy Men.A multimarker approach to diagnose and stratify heart failure.MicroRNAs in HPV associated cancers: small players with big consequences.Evaluation of saliva collection devices for the analysis of proteins.The saliva microbiome profiles are minimally affected by collection method or DNA extraction protocols.A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severityDNA Methylation at the Novel CpG Sites in the Promoter of MED15/PCQAP Gene as a Biomarker for Head and Neck Cancers.Authors's reply.The overexpression of salivary cytokeratins as potential diagnostic biomarkers in head and neck squamous cell carcinomas.Identification of salivary N-glycoproteins and measurement of glycosylation site occupancy by boronate glycoprotein enrichment and liquid chromatography/electrospray ionization tandem mass spectrometry.Metabolic response to a mixed meal in obese and lean women from two South african populations.A rapid and cost-effective method of producing recombinant proBNP and NT-proBNP variants in Escherichia coli for immunoassay of heart failure.Triphasic pattern in the ex vivo response of human proliferative phase endometrium to oestrogens.
P50
Q26858916-B76BDAC7-74B4-40F0-8A1D-2327A4FF4708Q28596009-9991A4FB-991F-4AFB-A868-E53EF5DA7A8CQ30361741-4D7AE9E6-5AA6-4859-B052-7DE4E8A7C9FFQ33305325-5DE6B517-59FB-4CA1-A96D-8E720B6A160CQ33697273-F96E1CF3-FF95-4BBE-841E-013BB27EACDEQ33852100-283BC773-0F8F-4D05-BC78-B13640C0B7C2Q34206306-C27CCFA3-E478-4734-9D48-E4EC89E0EAC1Q34401524-CA621DD7-1C83-4B1A-97F7-66293B75CD7BQ34465119-D3F5B5FD-6066-4F0D-B219-761FC584EFDDQ34615179-BB10ABE7-DE9B-4255-9636-4AD445F05EC1Q35121883-8945EF29-337C-4239-9D5B-0048C344171EQ35469459-60ED8B8A-4BF8-4328-AC06-C54224F907F5Q35945485-A01028CF-D288-4051-BFC2-122B128714B9Q36143417-CDDEC15D-D101-4DFF-8766-2AE65F04A886Q36310648-48D9EBF6-FF71-4188-A5F3-CADC25962008Q36578189-F749E027-DB7E-4597-826D-BB86B14205EDQ36856204-48EE388D-1FE0-44C3-BF78-837084B2ACB1Q37642572-E3493612-E7FA-4E8B-AF75-EAA4B54D8843Q37687598-BAEF2472-A06F-4225-ACFC-442E356232BBQ37729971-4EFB5101-B361-4C70-889B-6B21FD93B569Q37850622-10656BB7-ABF2-48EF-B04F-DA21D641A420Q38011759-FDB72456-3ED5-48D2-92FF-1078A51761D3Q38249250-7BDF0D25-6FF0-4CD7-92DA-EB0488C5AA94Q38397373-86640A8A-A587-439E-9183-265472781BB6Q38657288-D95D0A16-AD27-47B6-B690-17673ED5C477Q38703882-CE9E4C3D-33C7-4AEA-B00F-182284767BABQ38738057-0E402061-95C0-4FE2-B74C-538896C11DB0Q38758868-2C729F79-54B2-40F3-8F09-1D9EE15093ECQ39065122-59A8E428-B9B3-4258-A9AE-53A31A4BE9AAQ39361627-450590DC-60EE-4EE5-ACF3-653FEDE8D581Q39642683-011899A6-1E79-421B-9EEC-34AD3DF9302BQ41446871-E0F11E4A-CB01-422F-9DC5-94EC775C27EAQ41826626-372CDD3B-DB22-403E-B051-387B4F86A4EAQ42176436-7A346441-3A60-474E-80AA-E6A0B7FF1AE4Q42427386-955ED007-C63E-404D-8361-EAEA4F35CF01Q42700808-558D10F6-258E-497B-9727-181E238423F5Q43860434-68F318FD-2126-4B51-8B1D-64443A03C89CQ44255049-F808DC25-6A29-4787-94CB-75A76BFF1B9DQ44683095-96E45321-D669-4896-B0CA-42969E00BEF5Q45157594-6E68A33F-1DE7-4E9F-8F6E-E774DDDC728F
P50
description
researcher ORCID ID = 0000-0001-9039-8259
@en
name
Chamindie Punyadeera
@ast
Chamindie Punyadeera
@en
Chamindie Punyadeera
@es
Chamindie Punyadeera
@nl
type
label
Chamindie Punyadeera
@ast
Chamindie Punyadeera
@en
Chamindie Punyadeera
@es
Chamindie Punyadeera
@nl
prefLabel
Chamindie Punyadeera
@ast
Chamindie Punyadeera
@en
Chamindie Punyadeera
@es
Chamindie Punyadeera
@nl
P1153
16231145500
P31
P496
0000-0001-9039-8259